5AM Venture Management disclosed a full exit from Dianthus Therapeutics (NASDAQ:DNTH) on February 17, 2026, selling 365,053 shares worth $14.36 million in the fourth quarter. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, 5AM Venture Management sold its entire stake of 365,053 shares in Dianthus Therapeutics. The quarter-end value of the position decreased by $14.36 million as a result of the exit. What else to know Top holdings after the filing: ...